A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes

Overview

Journal J Environ Pathol Toxicol Oncol

Publisher Begell House

Date 2024 Mar 20

PMID 38505912

Authors

Sudhir Kotnala

Anupam Dhasmana

Swati Dhasmana

Shafiul Haque

Murali M Yallapu

Manish K Tripathi

Meena Jaggi

Subhash C Chauhan

Affiliations

Soon will be listed here.

Abstract

Gastrointestinal (GI) cancers comprise of cancers that affect the digestive system and its accessory organs. The late detection and poor prognosis of GI cancer emphasizes the importance of identifying reliable and precise biomarkers for early diagnosis and prediction of prognosis. The membrane-bound glycoprotein dipeptidyl-peptidase 4 (DPP4), also known as CD26, is ubiquitously expressed and has a wide spectrum of biological roles. The role of DPP4/CD26 in tumor progression in different types of cancers remains elusive. However, the link between DPP4 and tumor-infiltrating cells, as well as its prognostic significance in malignancies, still require further investigation. This study was intended to elucidate the correlation of DPP4 expression and survival along with prognosis, followed by its associated enriched molecular pathways and immune cell marker levels in upper GI cancers. Results demonstrated a strong correlation between increased DPP4 expression and a worse prognosis in esophageal and gastric cancer and the co-expressed common genes with DPP4 were associated with crucial molecular pathways involved in tumorigenesis. Additionally, DPP4 was shown to be significantly linked to several immune infiltrating cell marker genes, including Macrophages (M1, M2 and Tumor Associated Macrophages), neutrophils, Treg, T-cell exhaustion, Th1 and Th2. Overall, our findings suggest that DPP4 may serve as a substantial prognostic biomarker, a possible therapeutic target, as well as it can play a critical role in the regulation of immune cell invasion in patients with gastroesophageal (esophageal, gastroesophageal junction and gastric) cancer. KEY WORDS: DPP4, integrated analysis, GI cancer, gastroesophageal cancer, gastroesophageal junction, prognosis.

References

Alves Martins B, de Bulhoes G, Cavalcanti I, Martins M, de Oliveira P, Martins A . Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research. Front Oncol. 2019; 9:1284. PMC: 6890575. DOI: 10.3389/fonc.2019.01284. View

Gonzalez-Pons M, Cruz-Correa M . Colorectal Cancer Biomarkers: Where Are We Now?. Biomed Res Int. 2015; 2015:149014. PMC: 4461726. DOI: 10.1155/2015/149014. View

Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F, Mizutani S . Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer. 2004; 110(5):652-9. DOI: 10.1002/ijc.20183. View

Dhakras P, Uboha N, Horner V, Reinig E, Matkowskyj K . Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma. Transl Gastroenterol Hepatol. 2020; 5:55. PMC: 7530320. DOI: 10.21037/tgh.2020.01.08. View

Wilson M, Ruhland A, Quast B, Reddy P, Ewing S, Sinha A . Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl. 2000; 21(2):220-6. View

Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C . CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2018; 47(D1):D721-D728. PMC: 6323899. DOI: 10.1093/nar/gky900. View

Pang R, Lun Law W, Chu A, Poon J, Lam C, Chow A . A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 2010; 6(6):603-15. DOI: 10.1016/j.stem.2010.04.001. View

Lopez-Otin C, Matrisian L . Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007; 7(10):800-8. DOI: 10.1038/nrc2228. View

Chien C, Huang L, Chou C, Chen Y, Han Y, Chang G . One site mutation disrupts dimer formation in human DPP-IV proteins. J Biol Chem. 2004; 279(50):52338-45. DOI: 10.1074/jbc.M406185200. View

10.

Kameoka J, Tanaka T, Nojima Y, Schlossman S, Morimoto C . Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 1993; 261(5120):466-9. DOI: 10.1126/science.8101391. View

11.

Bjelakovic G, Nikolova D, Simonetti R, Gluud C . Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev. 2008; (3):CD004183. DOI: 10.1002/14651858.CD004183.pub3. View

12.

Huang Y, Zhu C, Kondo Y, Anderson A, Gandhi A, Russell A . CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2014; 517(7534):386-90. PMC: 4297519. DOI: 10.1038/nature13848. View

13.

Dang N, Torimoto Y, Sugita K, Daley J, Schow P, Prado C . Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol. 1990; 145(12):3963-71. View

14.

Wang W, Wang R, Zhang Z, Li D, Yut Y . Enhanced PPAR-gamma expression may correlate with the development of Barrett's esophagus and esophageal adenocarcinoma. Oncol Res. 2011; 19(3-4):141-7. DOI: 10.3727/096504011x12935427587849. View

15.

Rohrborn D, Eckel J, Sell H . Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Lett. 2014; 588(21):3870-7. DOI: 10.1016/j.febslet.2014.08.029. View

16.

Boutilier A, Elsawa S . Macrophage Polarization States in the Tumor Microenvironment. Int J Mol Sci. 2021; 22(13). PMC: 8268869. DOI: 10.3390/ijms22136995. View

17.

Ma X, Yu H, Huai N . Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma. World J Gastroenterol. 2009; 15(31):3874-83. PMC: 2731249. DOI: 10.3748/wjg.15.3874. View

18.

Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S . Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 2003; 63(9):2278-83. View

19.

Goscinski M, Suo Z, Nesland J, Chen W, Zakrzewska M, Wang J . Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology. 2008; 75(1-2):49-59. DOI: 10.1159/000151741. View

20.

Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y . Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013; 500(7461):227-31. PMC: 7095341. DOI: 10.1038/nature12328. View